All Blog Posts

EIGER2 X Detector Repairs

Submitted by kperry on Tue, 06/15/2021 - 12:02

At the start up of operations for the 2021-2 run, it was discovered that one of the cards which aggregates data from multiple modules in the EIGER2 detector on 24-ID-C was faulty.  As a result, NE-CAT was forced to reschedule all users on 24-ID-C for the first week of user operations.  However, Dectris was able to immediately send us a replacement part which was successfully installed by Ed Lynch, Jim Withrow, and Malcolm Capel.  Replacing the card did require removal of the EIGER2 from the 24-ID-C A-frame and its subsequent re-installation.

APS 'Dark' Period Rescheduled

Submitted by kperry on Mon, 05/10/2021 - 13:34

At the Plenary Session for the APS/CNM User Meeting, it was announced that the storage ring installation period of the Advanced Photon Source Upgrade project is now scheduled to begin April 17, 2023.  NE-CAT and the APS will be 'dark' for 1 year following this date.

Speakers at Current and Future Trends in Macromolecular Crystallography Experiments

Submitted by kperry on Mon, 03/08/2021 - 12:15

Malcolm Capel and Frank Murphy will be speaking at "Current and Future Trends in Macromolecular Crystallography Experiments." This workshop is hosted by NSLS-II and will be held virtually March 16-18, 2021. The workshop will be from 12pm - 6pm EST each day.

Malcolm will be speaking in Session I (March 16, 2021).  His talk is entitled, "New endstations at NE-CAT:  MD3UP microdiffractometer and 30 puck ALS-style loader."

A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein

Submitted by kperry on Tue, 03/24/2020 - 12:51

SARS-CoV-2 is a zoonotic virus that has caused a pandemic of severe respiratory disease—COVID-19— within several months of its initial identification. Comparable to the first SARS-CoV, this novel coronavirus’s surface Spike (S) glycoprotein mediates cell entry via the human ACE-2 receptor, and, thus, is the principal target for the development of vaccines and immunotherapeutics.

Pages